by Cort Johnson | Jun 28, 2025 | B-cells , Cardiovascular , Complement , Connective Tissues , Endothelial Cells , Energy Production , Exercise , Homepage , Immune , long COVID , Metabolism , Muscles
Conference findings suggest multiple barriers to blood flows could be causing chronic fatigue syndrome (ME/CFS) and long COVID.
by Cort Johnson | Jun 11, 2025 | Baritcinib , COVID-19 , Cytokines , Drugs , Gut , Homepage , Immune , Inflammation , long COVID , Metformin , Microbiome , Monocytes , Oxidative Stress , Rapamycin , Research , T-cells , Treatment
Profound immune dysregulation could be the tipping point that turns a COVID-19 patient into a long COVID patient.
by Cort Johnson | May 28, 2025 | GLP-1 , Homepage , Inflammation , Kaufman , long COVID , Mast cell activation syndrome , Mast cell activation syndrome , Metabolism , Microbiome , Neuroinflammation , Ruhoy
GLP-1 agonists like Ozempic could be surprisingly helpful in diseases like chronic fatigue syndrome, fibromyalgia and long COVID.
by Cort Johnson | Apr 24, 2025 | Antivirals , Apheresis , Apheresis , Drugs , Homepage , Immune , Ivabradine , IVIG , Ketamine , Klimas , long COVID , ME/CFS , Metabolism , Metformin , Monoclonal antibodies , Plasmapheresis , Rapamycin , Treatment
Big pharma is largely staying clear of long COVID trials but the many small and some quite large clinical trials are underway provide hope.
by Cort Johnson | Mar 20, 2025 | Energy Production , Homepage , long COVID , Metabolism , Muscles , Purine inhibitors , Research , Suramin , Treatment
A long COVID invasive exercise metabolomic study found reduced energy production and recommended purine inhibiting drugs.
by Cort Johnson | Mar 8, 2025 | Apheresis , Autoimmune , Homepage , Immune , long COVID , Scheibenbogen , Treatment
Plasma apheresis presents the enticing possibility of removing pathogenic substances from the blood of people with ME/CFS, long COVID and fibromyalgiz